Original paper

Long-term use of 5α-reductase inhibitors and the risk of male breast cancer

Volume: 25, Issue: 11, Pages: 1577 - 1582
Published: Aug 19, 2014
Abstract
Background The 5α-reductase inhibitors (5-ARI) finasteride and dutasteride are indicated for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia. Case reports have suggested that 5-ARIs increase the risk for male breast cancer, with no conclusive evidence. The objective of this study was to quantify the association between use of 5-ARIs and the risk for male breast...
Paper Details
Title
Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
Published Date
Aug 19, 2014
Volume
25
Issue
11
Pages
1577 - 1582
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.